218 related articles for article (PubMed ID: 24743888)
1. The effects of the CCR6/CCL20 biological axis on the invasion and metastasis of hepatocellular carcinoma.
Du D; Liu Y; Qian H; Zhang B; Tang X; Zhang T; Liu W
Int J Mol Sci; 2014 Apr; 15(4):6441-52. PubMed ID: 24743888
[TBL] [Abstract][Full Text] [Related]
2. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway.
Guo W; Li H; Liu H; Ma X; Yang S; Wang Z
Oncol Rep; 2019 Sep; 42(3):1075-1089. PubMed ID: 31322256
[TBL] [Abstract][Full Text] [Related]
3. The involvement of cell surface nucleolin in the initiation of CCR6 signaling in human hepatocellular carcinoma.
Qiu W; Wang G; Sun X; Ye J; Wei F; Shi X; Lv G
Med Oncol; 2015 Mar; 32(3):75. PubMed ID: 25698534
[TBL] [Abstract][Full Text] [Related]
4. Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis.
Chen KJ; Lin SZ; Zhou L; Xie HY; Zhou WH; Taki-Eldin A; Zheng SS
PLoS One; 2011; 6(9):e24671. PubMed ID: 21935436
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between CCL20/CCR6/Th17 axis and vascular invasion and metastasis in patients with primary hepatocellular carcinoma].
Chang X; Wang L; Zang M; Rong W; Wu Z; Liu L; Du J; Liu J; Wu J; Qu C
Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):5-10. PubMed ID: 25877311
[TBL] [Abstract][Full Text] [Related]
6. HOXD3 promotes the migration and angiogenesis of hepatocellular carcinoma via modifying hepatocellular carcinoma cells exosome-delivered CCR6 and regulating chromatin conformation of CCL20.
Wang L; Qiao C; Han L; Wang X; Miao J; Cao L; Huang C; Wang J
Cell Death Dis; 2024 Mar; 15(3):221. PubMed ID: 38493218
[TBL] [Abstract][Full Text] [Related]
7. CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer.
Benkheil M; Van Haele M; Roskams T; Laporte M; Noppen S; Abbasi K; Delang L; Neyts J; Liekens S
Exp Cell Res; 2018 Nov; 372(2):168-177. PubMed ID: 30287142
[TBL] [Abstract][Full Text] [Related]
8. Chemokine/chemokine receptor pair CCL20/CCR6 in human colorectal malignancy: An overview.
Frick VO; Rubie C; Keilholz U; Ghadjar P
World J Gastroenterol; 2016 Jan; 22(2):833-41. PubMed ID: 26811629
[TBL] [Abstract][Full Text] [Related]
9. Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma.
Ikeda S; Kitadate A; Ito M; Abe F; Nara M; Watanabe A; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
Oncotarget; 2016 Mar; 7(12):13563-74. PubMed ID: 26789110
[TBL] [Abstract][Full Text] [Related]
10. Chemokines and hepatocellular carcinoma.
Huang F; Geng XP
World J Gastroenterol; 2010 Apr; 16(15):1832-6. PubMed ID: 20397259
[TBL] [Abstract][Full Text] [Related]
11. The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer.
Ghadjar P; Rubie C; Aebersold DM; Keilholz U
Int J Cancer; 2009 Aug; 125(4):741-5. PubMed ID: 19480006
[TBL] [Abstract][Full Text] [Related]
12. The CCL20-CCR6 Axis in Cancer Progression.
Kadomoto S; Izumi K; Mizokami A
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707869
[TBL] [Abstract][Full Text] [Related]
13. CCL20/CCR6 promotes the invasion and migration of thyroid cancer cells via NF-kappa B signaling-induced MMP-3 production.
Zeng W; Chang H; Ma M; Li Y
Exp Mol Pathol; 2014 Aug; 97(1):184-90. PubMed ID: 24984269
[TBL] [Abstract][Full Text] [Related]
14. Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases.
Rubie C; Frick VO; Wagner M; Weber C; Kruse B; Kempf K; König J; Rau B; Schilling M
World J Gastroenterol; 2006 Nov; 12(41):6627-33. PubMed ID: 17075975
[TBL] [Abstract][Full Text] [Related]
15. Effect of preoperative FOLFOX chemotherapy on CCL20/CCR6 expression in colorectal liver metastases.
Rubie C; Frick VO; Ghadjar P; Wagner M; Justinger C; Graeber S; Sperling J; Kollmar O; Schilling MK
World J Gastroenterol; 2011 Jul; 17(26):3109-16. PubMed ID: 21912453
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression and clinical significance of CC-chemokine MIP-3 alpha in hepatocellular carcinoma.
Rubie C; Frick VO; Wagner M; Rau B; Weber C; Kruse B; Kempf K; Tilton B; König J; Schilling M
Scand J Immunol; 2006 Jun; 63(6):468-77. PubMed ID: 16764701
[TBL] [Abstract][Full Text] [Related]
17. Modulation of chemotactic and pro-inflammatory activities of endothelial progenitor cells by hepatocellular carcinoma.
Shih YT; Wang MC; Peng HH; Chen TF; Chen L; Chang JY; Chiu JJ
Cell Signal; 2012 Mar; 24(3):779-93. PubMed ID: 22120522
[TBL] [Abstract][Full Text] [Related]
18. CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis.
Nandi B; Pai C; Huang Q; Prabhala RH; Munshi NC; Gold JS
PLoS One; 2014; 9(5):e97566. PubMed ID: 24866282
[TBL] [Abstract][Full Text] [Related]
19. CCL20/CCR6 promotes cell proliferation and metastasis in laryngeal cancer by activating p38 pathway.
Lu E; Su J; Zhou Y; Zhang C; Wang Y
Biomed Pharmacother; 2017 Jan; 85():486-492. PubMed ID: 27916417
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma.
Ito M; Teshima K; Ikeda S; Kitadate A; Watanabe A; Nara M; Yamashita J; Ohshima K; Sawada K; Tagawa H
Blood; 2014 Mar; 123(10):1499-511. PubMed ID: 24385540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
